Skip to main content

Cytokines Pathway

  • Chapter
  • First Online:
Textbook of Cell Signalling in Cancer
  • 3058 Accesses

Abstract

An important group of signalling molecules operate through a pathway which is slightly different from that described in Chap. 1: their receptors do not present tyrosine kinase activity but are coupled to a cytoplasmic tyrosine kinase which ensures, after receptor activation, the transduction of a signal leading to the transcription of target genes. The main signalling pathway downstream the activation of these receptors by their ligands involves cytoplasmic JAK (just another kinase, now Janus kinase) proteins and STAT (signal transducer and activator of transcription) transcription factors, but the activation of other kinases is sometimes possible, with connections with the MAP kinases (Chap. 2) and the PI3 kinase (Chap. 3) pathways.

Whereas the word ‘cytokine’ designates often a large variety of signalling proteins, including growth factors (Chap. 1), TNF-related factors and chemokines (Chap. 6), we will adopt a mechanistic definition and restrict this denomination to the ligands of membrane receptors devoid of tyrosine kinase activity but coupled with cytoplasmic tyrosine kinases. This includes most interleukins and interferons, but excludes many signalling molecules that activate other receptors, such as tyrosine kinase receptors, death receptors, interleukin-1 and toll-like receptors, etc. The cytokines envisaged in this chapter may be involved in multiple cell processes: proliferation and differentiation of blood cells, immunity and inflammation, body weight and size control, antiviral defences, etc.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Benekli M, Baumann H, Wetzler M. Targeting signal transducer and activator of transcription signaling pathway in leukemias. J Clin Oncol. 2009;27:4422–32.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Constantinescu SN, Girardot M, Pecquet C. Mining for JAK–STAT mutations in cancer. Trends Biochem Sci. 2007;33:122–31.

    Article  Google Scholar 

  • Gadina M, Hilton D, Johnston JA, Morinobu A, Lighvani A, Zhou YJ, Visconti R, O’Shea JJ. Signaling by type I and II cytokine receptors: ten years after. Curr Opin Immunol. 2001;13:363–73.

    Article  CAS  PubMed  Google Scholar 

  • Germain D, Frank DA. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin Cancer Res. 2007;13:5665–9.

    Article  CAS  PubMed  Google Scholar 

  • Guo Y, Xu F, Lu T, Duan Z, Zhang Z. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012;38:904–10.

    Article  CAS  PubMed  Google Scholar 

  • Haan C, Kreis S, Margue C, Behrmann I. Jaks and cytokine receptors – an intimate relationship. Biochem Pharmacol. 2006;72:1538–46.

    Article  CAS  PubMed  Google Scholar 

  • Ihle JN. Cytokine receptor signalling. Nature. 1995;377:591–4.

    Article  CAS  PubMed  Google Scholar 

  • Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol. 1995;13:369–98.

    Article  CAS  PubMed  Google Scholar 

  • Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell. 1994;76:253–62.

    Article  CAS  PubMed  Google Scholar 

  • Miklossy G, Hilliard TS, Turkson J. Therapeutic modulators of STAT signalling for human diseases. Nat Rev Drug Discov. 2013;12:611–29.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Moutoussamy S, Kelly PA, Finidori J. Growth-hormone-receptor and cytokine-receptor-family signaling. Eur J Biochem. 1998;255:1–11.

    Article  CAS  PubMed  Google Scholar 

  • Mullally A, Ebert BL. Janus reveals another face: the biologic rationale for targeting Janus kinase 2 in lymphoma. J Clin Oncol. 2012;30:4168–70.

    Article  PubMed  Google Scholar 

  • Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol. 2007;178:2623–9.

    Article  CAS  PubMed  Google Scholar 

  • O’Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 2002;109:S121–31.

    Article  PubMed  Google Scholar 

  • O’Sullivan LA, Liongue C, Lewis RS, Stephenson SEM, Ward AC. Cytokine receptor signaling through the Jak–Stat–Socs pathway in disease. Mol Immunol. 2007;44:2497–506.

    Article  PubMed  Google Scholar 

  • Pesu M, Laurence A, Kishore N, Zwillich SH, Chan G, O’Shea JJ. Therapeutic targeting of Janus kinases. Immunol Rev. 2008;223:132–42.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Quintás-Cardama A, Verstovsek S. Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance. Clin Cancer Res. 2013;19:1933–40.

    Article  PubMed  Google Scholar 

  • Renauld JC. Class II, cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol. 2003;3:667–76.

    Article  CAS  PubMed  Google Scholar 

  • Santos CI, Costa-Pereira AP. Signal transducers and activators of transcription-from cytokine signalling to cancer biology. Biochim Biophys Acta. 1816;2011:38–49.

    Google Scholar 

  • Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science. 1995;268:251–5.

    Article  CAS  PubMed  Google Scholar 

  • Tayal V, Kalra BS. Cytokines and anti-cytokines as therapeutics – an update. Eur J Pharmacol. 2008;579:1–12.

    Article  CAS  PubMed  Google Scholar 

  • Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 2006;97:439–47.

    Article  CAS  PubMed  Google Scholar 

  • Zhang J, Li H, Yu JP, Wang SE, Ren XB. Role of SOCS1 in tumor progression and therapeutic application. Int J Cancer. 2012;130:1971–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Robert, J. (2015). Cytokines Pathway. In: Textbook of Cell Signalling in Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-14340-8_4

Download citation

Publish with us

Policies and ethics